Description
Composition
Each Denverkast® 10 mg film-coated tablet contains: Montelukast (as sodium salt) 10.00 mg. Excipients: q. s.
Therapeutic Action
Antiasthmatic and antiallergic for systemic use. Antagonist of leukotriene receptors.
Indications
Asthma
Prophylaxis and treatment of asthma in adult patients, and pediatric patients from 12 months of age. Bronchoconstriction induced by exercise.
Prevention of exercise-induced bronchoconstriction in pediatric patients aged 6 years and older.
Allergic rhinitis
Indicated for the relief of symptoms of seasonal allergic rhinitis in adult and pediatric patients from 2 years of age and perennial allergic rhinitis in adult and pediatric patients from 6 months of age.
Presentations
DENVERKAST 10 mg: Containers with 30 tablets
